Chissov V I, Ageenko A I, Vashakmadze L A, Babaian L A, Shcherbitskaia I Ia, Drakina L V, Zubova Iu E
Sov Med. 1991(8):30-2.
Autoinoculation is suggested as an adjuvant means to augment the effect of surgery in gastric cancer which may prevent the development of recurrences and metastases. Surgery alone is not a curative method and 5-year survival in gastric cancer stage III ranges from 9.2 to 28%. The data have been obtained on comparative survival in a control group and a group of inoculated patients. The greatest effect was achieved in patients with poorly differentiated adenocarcinoma. Further investigation of the two groups adjusted for the patients' age, kind of surgery and morphological structure of the tumor will help to work out precise criteria for inoculation.
自体接种被认为是一种辅助手段，可增强胃癌手术的效果，这可能会预防复发和转移的发生。单纯手术并非一种根治性方法，III期胃癌患者的5年生存率在9.2%至28%之间。已获得了对照组和接种患者组的对比生存数据。在低分化腺癌患者中取得了最大效果。对两组患者的年龄、手术类型和肿瘤形态结构进行进一步调整研究，将有助于制定精确的接种标准。
